524 related articles for article (PubMed ID: 26869641)
1. Trimethylamine N-oxide and prognosis in acute heart failure.
Suzuki T; Heaney LM; Bhandari SS; Jones DJ; Ng LL
Heart; 2016 Jun; 102(11):841-8. PubMed ID: 26869641
[TBL] [Abstract][Full Text] [Related]
2. [Predictive value of plasma TMAO combined with NT-proBNP on the prognosis and length of hospitalization of patients with ischemic heart failure].
Qiu WD; Xiao XJ; Xia S; Gao ZP; Li LW
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):684-689. PubMed ID: 35856225
[No Abstract] [Full Text] [Related]
3. Association of gut-related metabolites with outcome in acute heart failure.
Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Heaney LM; Jones DJL; Ng LL; Suzuki T
Am Heart J; 2021 Apr; 234():71-80. PubMed ID: 33454370
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
[TBL] [Abstract][Full Text] [Related]
5. The Additional Prognostic Value of Ghrelin for Mortality and Readmission in Elderly Patients with Acute Heart Failure.
Yuan Y; Huang F; Deng C; Zhu P
Clin Interv Aging; 2020; 15():1353-1363. PubMed ID: 32848376
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
[TBL] [Abstract][Full Text] [Related]
7. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
[TBL] [Abstract][Full Text] [Related]
9. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
[TBL] [Abstract][Full Text] [Related]
11. Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF.
Suzuki T; Yazaki Y; Voors AA; Jones DJL; Chan DCS; Anker SD; Cleland JG; Dickstein K; Filippatos G; Hillege HL; Lang CC; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; Metra M; Ng LL
Eur J Heart Fail; 2019 Jul; 21(7):877-886. PubMed ID: 30370976
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
13. Incremental Predictive Value of Plasma Renin Activity as a Prognostic Biomarker in Patients with Heart Failure.
Park BE; Yang DH; Kim HJ; Park YJ; Kim HN; Jang SY; Bae MH; Lee JH; Park HS; Cho Y; Chae SC
J Korean Med Sci; 2020 Nov; 35(42):e351. PubMed ID: 33140588
[TBL] [Abstract][Full Text] [Related]
14. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
[TBL] [Abstract][Full Text] [Related]
15. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.
Ballo P; Betti I; Barchielli A; Balzi D; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
Clin Res Cardiol; 2016 May; 105(5):421-31. PubMed ID: 26547915
[TBL] [Abstract][Full Text] [Related]
17. The use of discharge haemoglobin and NT-proBNP to improve short and long-term outcome prediction in patients with acute heart failure.
Stojcevski B; Celic V; Navarin S; Pencic B; Majstorovic A; Sljivic A; Magrini L; Cristofano F; Cavalieri L; Di Somma S;
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):676-684. PubMed ID: 25943556
[TBL] [Abstract][Full Text] [Related]
18. GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome.
Kosum P; Siranart N; Mattanapojanat N; Phutinart S; Kongruttanachok N; Sinphurmsukskul S; Siwamogsatham S; Puwanant S; Ariyachaipanich A
BMC Cardiovasc Disord; 2024 Mar; 24(1):151. PubMed ID: 38475710
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
Leto L; Testa M; Feola M
Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
[TBL] [Abstract][Full Text] [Related]
20. The impact of admission cystatin C levels on in-hospital and three-year mortality rates in acute decompensated heart failure.
Selcuk H; Selcuk MT; Maden O; Balci KG; Balci MM; Tekeli S; Çetin EH; Temizhan A; Balci M; Karabiber N
Cardiovasc J Afr; 2018 Sep/Oct 23; 29(5):305-309. PubMed ID: 30059128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
